Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Inogen IncINGN · Entity 2083 | Director | September 15, 2021 | September 17, 2021 |
| TACTILE SYSTEMS TECHNOLOGY INCTCMD · Entity 5451 | Director | May 06, 2026 | May 08, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Inogen Inc
Report date September 15, 2021 · Filed September 17, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 17,583 |
Ending reported balance
After 2021-09-15 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2021-09-15 · Exercise / conversion · Acquired 4,000 · Balance 21,583 Row 2 · 2021-09-15 · Sale · Disposed 4,000 · Balance 17,583 F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 1, 2021. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $38.54 · Expires 2022-05-15 | Direct | 11,806 |
Reported balance
After 2021-09-15 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2021-09-15 · Exercise / conversion · Disposed 4,000 · Balance 11,806 F2: Subject to the reporting person's continuing service, twenty-five percent (25%) of the shares subject to the option shall vest and become exercisable on the one year anniversary of the vesting commencement date, and thereafter, one forty-eighth (1/48th) of the total shares subject to the option shall vest each month on the same day as the vesting commencement date. The vesting commencement date for this option was May 1, 2015. |
Filing footnotes · ownership attribution and instrument terms
F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 1, 2021.
F2: Subject to the reporting person's continuing service, twenty-five percent (25%) of the shares subject to the option shall vest and become exercisable on the one year anniversary of the vesting commencement date, and thereafter, one forty-eighth (1/48th) of the total shares subject to the option shall vest each month on the same day as the vesting commencement date. The vesting commencement date for this option was May 1, 2015.
TACTILE SYSTEMS TECHNOLOGY INC
Report date May 06, 2026 · Filed May 08, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 62,841 |
Reported balance
After 2026-05-06 transaction · row 1
1 source rowRow 1 · 2026-05-06 · Grant · Acquired 6,521 · Balance 62,841 F1: The restricted stock units will vest in full on the earlier of one year from the grant date or the date of the next year's annual meeting of the stockholders. |
Filing footnotes · ownership attribution and instrument terms
F1: The restricted stock units will vest in full on the earlier of one year from the grant date or the date of the next year's annual meeting of the stockholders.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
INTRICON CORP
Report date May 24, 2022 · Filed May 25, 2022
Section 16 reporting ended · disclosed 2022-05-25. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2022-05-24 transaction · row 1
1 source rowRow 1 · 2022-05-24 · Disposition to issuer · Disposed 11,154 · Balance 0 F1: Disposed of pursuant to an Agreement and Plan of Merger, dated as of February 27, 2022 (the "Merger Agreement") by and among the Issuer, IIN Holding Company Inc., a Delaware corporation ("Parent"), and IC Merger Sub Inc., a Pennsylvania corporation and a wholly-owned subsidiary of Parent ("Merger Sub"), pursuant to which Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as a wholly-owned subsidiary of Parent. Each share of common stock exchanged in the Merger will receive cash of $24.25 per share. |
Filing footnotes · ownership attribution and instrument terms
F1: Disposed of pursuant to an Agreement and Plan of Merger, dated as of February 27, 2022 (the "Merger Agreement") by and among the Issuer, IIN Holding Company Inc., a Delaware corporation ("Parent"), and IC Merger Sub Inc., a Pennsylvania corporation and a wholly-owned subsidiary of Parent ("Merger Sub"), pursuant to which Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as a wholly-owned subsidiary of Parent. Each share of common stock exchanged in the Merger will receive cash of $24.25 per share.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 15, 2018 Filed Aug 17, 2018 00:24 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionStock Option (right to buy) · Derivative | 4,500 | $0.00 Strike: $16.62 | $0.00 |
DisclosureSEC source: 0001209191-18-047223 · doc4.xml · derivative · entry 12 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,656 Underlying: Common Stock · 4,500 shares Expires 2021-03-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_date: Subject to the reporting person's continuing service, 1/48th of the total shares subject to the option shall vest every month after March 1, 2014. Read SEC document |
| August 15, 2018 Filed Aug 17, 2018 00:24 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionStock Option (right to buy) · Derivative | 1,000 | $0.00 Strike: $8.37 | $0.00 |
DisclosureSEC source: 0001209191-18-047223 · doc4.xml · derivative · entry 11 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000 Underlying: Common Stock · 1,000 shares Expires 2023-10-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: Subject to the reporting person's continuing service, one forty-eighth (1/48th) of the shares subject to the option shall vest each month on the same day as the vesting commencement date, such that the shares subject to the option shall become fully vested and exercisable on the fourth (4th) anniversary of the vesting commencement date. The vesting commencement date for this option is October 1, 2013. Read SEC document |
| August 15, 2018 Filed Aug 17, 2018 00:24 UTC | Inogen Inc INGN · Entity 2083 | SaleCommon Stock | 200 | $231.07 | $46,213.70 |
DisclosureSEC source: 0001209191-18-047223 · doc4.xml · nonDerivative · entry 10 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,797 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 2, 2018. F7 · price: Represents the weighted average share price of an aggregate total of 200 shares sold in the price range of $231.03 to $231.22 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 15, 2018 Filed Aug 17, 2018 00:24 UTC | Inogen Inc INGN · Entity 2083 | SaleCommon Stock | 1,605 | $230.43 | $369,843.20 |
DisclosureSEC source: 0001209191-18-047223 · doc4.xml · nonDerivative · entry 9 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,997 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 2, 2018. F6 · price: Represents the weighted average share price of an aggregate total of 1,605 shares sold in the price range of $230.00 to $230.96 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 15, 2018 Filed Aug 17, 2018 00:24 UTC | Inogen Inc INGN · Entity 2083 | SaleCommon Stock | 3,701 | $229.43 | $849,117.47 |
DisclosureSEC source: 0001209191-18-047223 · doc4.xml · nonDerivative · entry 8 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,602 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 2, 2018. F5 · price: Represents the weighted average share price of an aggregate total of 3,701 shares sold in the price range of $229.00 to $229.84 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 15, 2018 Filed Aug 17, 2018 00:24 UTC | Inogen Inc INGN · Entity 2083 | SaleCommon Stock | 1,110 | $228.57 | $253,711.04 |
DisclosureSEC source: 0001209191-18-047223 · doc4.xml · nonDerivative · entry 7 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,303 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 2, 2018. F4 · price: Represents the weighted average share price of an aggregate total of 1,110 shares sold in the price range of $228.00 to $228.97 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 15, 2018 Filed Aug 17, 2018 00:24 UTC | Inogen Inc INGN · Entity 2083 | SaleCommon Stock | 3,178 | $227.18 | $721,993.61 |
DisclosureSEC source: 0001209191-18-047223 · doc4.xml · nonDerivative · entry 6 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,413 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 2, 2018. F3 · price: Represents the weighted average share price of an aggregate total of 3,178 shares sold in the price range of $226.76 to $227.60 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 15, 2018 Filed Aug 17, 2018 00:24 UTC | Inogen Inc INGN · Entity 2083 | SaleCommon Stock | 706 | $226.30 | $159,767.09 |
DisclosureSEC source: 0001209191-18-047223 · doc4.xml · nonDerivative · entry 5 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,591 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 2, 2018. F2 · price: Represents the weighted average share price of an aggregate total of 706 shares sold in the price range of $225.71 to $226.51 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 15, 2018 Filed Aug 17, 2018 00:24 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionCommon Stock | 2,500 | $44.19 | $110,475.00 |
DisclosureSEC source: 0001209191-18-047223 · doc4.xml · nonDerivative · entry 4 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,297 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 15, 2018 Filed Aug 17, 2018 00:24 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionCommon Stock | 2,500 | $38.54 | $96,350.00 |
DisclosureSEC source: 0001209191-18-047223 · doc4.xml · nonDerivative · entry 3 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,797 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 15, 2018 Filed Aug 17, 2018 00:24 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionCommon Stock | 4,500 | $16.62 | $74,790.00 |
DisclosureSEC source: 0001209191-18-047223 · doc4.xml · nonDerivative · entry 2 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,297 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 15, 2018 Filed Aug 17, 2018 00:24 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionCommon Stock | 1,000 | $8.37 | $8,370.00 |
DisclosureSEC source: 0001209191-18-047223 · doc4.xml · nonDerivative · entry 1 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,797 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 16, 2018 Filed Jul 17, 2018 22:24 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionStock Option (right to buy) · Derivative | 2,500 | $0.00 Strike: $44.19 | $0.00 |
DisclosureSEC source: 0001209191-18-042902 · doc4.xml · derivative · entry 14 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,800 Underlying: Common Stock · 2,500 shares Expires 2023-05-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F10 · derivative.exercise_date: Subject to the reporting person's continuing service, twenty-five percent (25%) of the shares subject to the option shall vest and become exercisable on the one year anniversary of the vesting commencement date, and thereafter, one forty-eighth (1/48th) of the shares subject to the option shall vest each month on the same day as the vesting commencement date, such that the shares subject to the option shall become fully vested and exercisable on the fourth (4th) anniversary of the vesting commencement date. The vesting commencement date for this option is May 1, 2016. Read SEC document |
| July 16, 2018 Filed Jul 17, 2018 22:24 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionStock Option (right to buy) · Derivative | 2,500 | $0.00 Strike: $38.54 | $0.00 |
DisclosureSEC source: 0001209191-18-042902 · doc4.xml · derivative · entry 13 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,400 Underlying: Common Stock · 2,500 shares Expires 2022-05-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_date: Subject to the reporting person's continuing service, twenty-five percent (25%) of the shares subject to the option shall vest and become exercisable on the one year anniversary of the vesting commencement date, and thereafter, one forty-eighth (1/48th) of the total shares subject to the option shall vest each month on the same day as the vesting commencement date. The vesting commencement date for this option is May 1, 2015. Read SEC document |
| July 16, 2018 Filed Jul 17, 2018 22:24 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionStock Option (right to buy) · Derivative | 4,500 | $0.00 Strike: $16.62 | $0.00 |
DisclosureSEC source: 0001209191-18-042902 · doc4.xml · derivative · entry 12 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,156 Underlying: Common Stock · 4,500 shares Expires 2021-03-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: Subject to the reporting person's continuing service, 1/48th of the total shares subject to the option shall vest every month after March 1, 2014. Read SEC document |
| July 16, 2018 Filed Jul 17, 2018 22:24 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionStock Option (right to buy) · Derivative | 1,093 | $0.00 Strike: $8.37 | $0.00 |
DisclosureSEC source: 0001209191-18-042902 · doc4.xml · derivative · entry 11 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,000 Underlying: Common Stock · 1,093 shares Expires 2023-10-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: Subject to the reporting person's continuing service, one forty-eighth (1/48th) of the shares subject to the option shall vest each month on the same day as the vesting commencement date, such that the shares subject to the option shall become fully vested and exercisable on the fourth (4th) anniversary of the vesting commencement date. The vesting commencement date for this option is October 1, 2013. Read SEC document |
| July 16, 2018 Filed Jul 17, 2018 22:24 UTC | Inogen Inc INGN · Entity 2083 | SaleCommon Stock | 500 | $197.29 | $98,645.00 |
DisclosureSEC source: 0001209191-18-042902 · doc4.xml · nonDerivative · entry 10 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,797 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 2, 2018. Read SEC document |
| July 16, 2018 Filed Jul 17, 2018 22:24 UTC | Inogen Inc INGN · Entity 2083 | SaleCommon Stock | 1,200 | $195.98 | $235,178.76 |
DisclosureSEC source: 0001209191-18-042902 · doc4.xml · nonDerivative · entry 9 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,297 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 2, 2018. F6 · price: Represents the weighted average share price of an aggregate total of 1,200 shares sold in the price range of $195.85 to $196.33 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| July 16, 2018 Filed Jul 17, 2018 22:24 UTC | Inogen Inc INGN · Entity 2083 | SaleCommon Stock | 4,199 | $195.17 | $819,536.05 |
DisclosureSEC source: 0001209191-18-042902 · doc4.xml · nonDerivative · entry 8 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,497 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 2, 2018. F5 · price: Represents the weighted average share price of an aggregate total of 4,199 shares sold in the price range of $194.80 to $195.78 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| July 16, 2018 Filed Jul 17, 2018 22:24 UTC | Inogen Inc INGN · Entity 2083 | SaleCommon Stock | 1,594 | $194.30 | $309,712.29 |
DisclosureSEC source: 0001209191-18-042902 · doc4.xml · nonDerivative · entry 7 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,696 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 2, 2018. F4 · price: Represents the weighted average share price of an aggregate total of 1,594 shares sold in the price range of $193.75 to $194.61 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| July 16, 2018 Filed Jul 17, 2018 22:24 UTC | Inogen Inc INGN · Entity 2083 | SaleCommon Stock | 2,484 | $192.92 | $479,217.75 |
DisclosureSEC source: 0001209191-18-042902 · doc4.xml · nonDerivative · entry 6 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,290 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 2, 2018. F3 · price: Represents the weighted average share price of an aggregate total of 2,484 shares sold in the price range of $192.57 to $193.36 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| July 16, 2018 Filed Jul 17, 2018 22:24 UTC | Inogen Inc INGN · Entity 2083 | SaleCommon Stock | 616 | $191.87 | $118,188.84 |
DisclosureSEC source: 0001209191-18-042902 · doc4.xml · nonDerivative · entry 5 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,774 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 2, 2018. F2 · price: Represents the weighted average share price of an aggregate total of 616 shares sold in the price range of $191.52 to $192.18 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| July 16, 2018 Filed Jul 17, 2018 22:24 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionCommon Stock | 2,500 | $44.19 | $110,475.00 |
DisclosureSEC source: 0001209191-18-042902 · doc4.xml · nonDerivative · entry 4 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,390 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 16, 2018 Filed Jul 17, 2018 22:24 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionCommon Stock | 2,500 | $38.54 | $96,350.00 |
DisclosureSEC source: 0001209191-18-042902 · doc4.xml · nonDerivative · entry 3 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,890 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 16, 2018 Filed Jul 17, 2018 22:24 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionCommon Stock | 4,500 | $16.62 | $74,790.00 |
DisclosureSEC source: 0001209191-18-042902 · doc4.xml · nonDerivative · entry 2 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,390 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 16, 2018 Filed Jul 17, 2018 22:24 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionCommon Stock | 1,093 | $8.37 | $9,148.41 |
DisclosureSEC source: 0001209191-18-042902 · doc4.xml · nonDerivative · entry 1 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,890 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 15, 2018 Filed Jun 18, 2018 23:38 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionStock Option (right to buy) · Derivative | 2,500 | $0.00 Strike: $44.19 | $0.00 |
DisclosureSEC source: 0001209191-18-038425 · doc4.xml · derivative · entry 9 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,300 Underlying: Common Stock · 2,500 shares Expires 2023-05-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Subject to the reporting person's continuing service, twenty-five percent (25%) of the shares subject to the option shall vest and become exercisable on the one year anniversary of the vesting commencement date, and thereafter, one forty-eighth (1/48th) of the shares subject to the option shall vest each month on the same day as the vesting commencement date, such that the shares subject to the option shall become fully vested and exercisable on the fourth (4th) anniversary of the vesting commencement date. The vesting commencement date for this option is May 1, 2016. Read SEC document |
| June 15, 2018 Filed Jun 18, 2018 23:38 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionStock Option (right to buy) · Derivative | 2,500 | $0.00 Strike: $38.54 | $0.00 |
DisclosureSEC source: 0001209191-18-038425 · doc4.xml · derivative · entry 8 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,900 Underlying: Common Stock · 2,500 shares Expires 2022-05-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Subject to the reporting person's continuing service, twenty-five percent (25%) of the shares subject to the option shall vest and become exercisable on the one year anniversary of the vesting commencement date, and thereafter, one forty-eighth (1/48th) of the total shares subject to the option shall vest each month on the same day as the vesting commencement date. The vesting commencement date for this option is May 1, 2015. Read SEC document |
| June 15, 2018 Filed Jun 18, 2018 23:38 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionStock Option (right to buy) · Derivative | 4,500 | $0.00 Strike: $16.62 | $0.00 |
DisclosureSEC source: 0001209191-18-038425 · doc4.xml · derivative · entry 7 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,656 Underlying: Common Stock · 4,500 shares Expires 2021-03-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Subject to the reporting person's continuing service, 1/48th of the total shares subject to the option shall vest every month after March 1, 2014. Read SEC document |
| June 15, 2018 Filed Jun 18, 2018 23:38 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionStock Option (right to buy) · Derivative | 944 | $0.00 Strike: $8.37 | $0.00 |
DisclosureSEC source: 0001209191-18-038425 · doc4.xml · derivative · entry 6 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,093 Underlying: Common Stock · 944 shares Expires 2023-10-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Subject to the reporting person's continuing service, one forty-eighth (1/48th) of the shares subject to the option shall vest each month on the same day as the vesting commencement date, such that the shares subject to the option shall become fully vested and exercisable on the fourth (4th) anniversary of the vesting commencement date. The vesting commencement date for this option is October 1, 2013. Read SEC document |
| June 15, 2018 Filed Jun 18, 2018 23:38 UTC | Inogen Inc INGN · Entity 2083 | SaleCommon Stock | 10,444 | $183.50 | $1,916,474.00 |
DisclosureSEC source: 0001209191-18-038425 · doc4.xml · nonDerivative · entry 5 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,797 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 2, 2018. Read SEC document |
| June 15, 2018 Filed Jun 18, 2018 23:38 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionCommon Stock | 2,500 | $44.19 | $110,475.00 |
DisclosureSEC source: 0001209191-18-038425 · doc4.xml · nonDerivative · entry 4 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,241 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 15, 2018 Filed Jun 18, 2018 23:38 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionCommon Stock | 2,500 | $38.54 | $96,350.00 |
DisclosureSEC source: 0001209191-18-038425 · doc4.xml · nonDerivative · entry 3 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,741 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 15, 2018 Filed Jun 18, 2018 23:38 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionCommon Stock | 4,500 | $16.62 | $74,790.00 |
DisclosureSEC source: 0001209191-18-038425 · doc4.xml · nonDerivative · entry 2 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,241 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 15, 2018 Filed Jun 18, 2018 23:38 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionCommon Stock | 944 | $8.37 | $7,901.28 |
DisclosureSEC source: 0001209191-18-038425 · doc4.xml · nonDerivative · entry 1 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,741 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 10, 2018 Filed May 14, 2018 21:47 UTC | TACTILE SYSTEMS TECHNOLOGY INC TCMD · Entity 5451 | GrantStock Option (right to buy) · Derivative | 3,713 | $0.00 Strike: $45.52 | $0.00 |
DisclosureSEC source: 0001437749-18-009810 · rdgdoc.xml · derivative · entry 2 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,713 Underlying: Common Stock · 3,713 shares Expires 2025-05-10 F2 · derivative.exercise_date: The options will vest in full on the earlier of one year from the grant date or the date of the next year's annual meeting of the stockholders. Read SEC document |
| May 10, 2018 Filed May 14, 2018 21:47 UTC | TACTILE SYSTEMS TECHNOLOGY INC TCMD · Entity 5451 | GrantCommon Stock | 1,373 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-18-009810 · rdgdoc.xml · nonDerivative · entry 1 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,617 F1 · shares: The restricted stock units will vest in full on the earlier of one year from the grant date or the date of the next year's annual meeting of the stockholders. Read SEC document |
| May 10, 2018 Filed May 14, 2018 21:40 UTC | Inogen Inc INGN · Entity 2083 | GrantCommon Stock | 989 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-029942 · doc4.xml · nonDerivative · entry 1 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,797 F1 · shares: The reported shares were acquired pursuant to a restricted stock unit award, which shall vest on the earlier of (i) the one-year anniversary of the date of grant, or (ii) the day prior to the date of the Annual Meeting of the Issuer's stockholders next following the date of grant, in each case, subject to the reporting person continuing to be a service provider through the applicable vesting date. Read SEC document |
| January 16, 2018 Filed Jan 18, 2018 21:49 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionStock Option (right to buy) · Derivative | 3,400 | $0.00 Strike: $44.19 | $0.00 |
DisclosureSEC source: 0001209191-18-004280 · doc4.xml · derivative · entry 7 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,800 Underlying: Common Stock · 3,400 shares Expires 2023-05-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Subject to the reporting person's continuing service, twenty-five percent (25%) of the shares subject to the option shall vest and become exercisable on the one year anniversary of the vesting commencement date, and thereafter, one forty-eighth (1/48th) of the shares subject to the option shall vest each month on the same day as the vesting commencement date, such that the shares subject to the option shall become fully vested and exercisable on the fourth (4th) anniversary of the vesting commencement date. The vesting commencement date for this option is May 1, 2016. Read SEC document |
| January 16, 2018 Filed Jan 18, 2018 21:49 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionStock Option (right to buy) · Derivative | 6,200 | $0.00 Strike: $38.54 | $0.00 |
DisclosureSEC source: 0001209191-18-004280 · doc4.xml · derivative · entry 6 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,400 Underlying: Common Stock · 6,200 shares Expires 2022-05-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Subject to the reporting person's continuing service, twenty-five percent (25%) of the shares subject to the option shall vest and become exercisable on the one year anniversary of the vesting commencement date, and thereafter, one forty-eighth (1/48th) of the total shares subject to the option shall vest each month on the same day as the vesting commencement date. The vesting commencement date for this option is May 1, 2015. Read SEC document |
| January 16, 2018 Filed Jan 18, 2018 21:49 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionStock Option (right to buy) · Derivative | 3,400 | $0.00 Strike: $16.62 | $0.00 |
DisclosureSEC source: 0001209191-18-004280 · doc4.xml · derivative · entry 5 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,156 Underlying: Common Stock · 3,400 shares Expires 2021-03-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Subject to the reporting person's continuing service, 1/48th of the total shares subject to the option shall vest every month after March 1, 2014. Read SEC document |
| January 16, 2018 Filed Jan 18, 2018 21:49 UTC | Inogen Inc INGN · Entity 2083 | SaleCommon Stock | 13,000 | $116.19 | $1,510,477.80 |
DisclosureSEC source: 0001209191-18-004280 · doc4.xml · nonDerivative · entry 4 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,808 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 3, 2017. F2 · price: Represents the weighted average share price of an aggregate total of 13,000 shares sold in the price range of $115.68 to $116.57 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| January 16, 2018 Filed Jan 18, 2018 21:49 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionCommon Stock | 3,400 | $44.19 | $150,246.00 |
DisclosureSEC source: 0001209191-18-004280 · doc4.xml · nonDerivative · entry 3 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,808 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 16, 2018 Filed Jan 18, 2018 21:49 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionCommon Stock | 6,200 | $38.54 | $238,948.00 |
DisclosureSEC source: 0001209191-18-004280 · doc4.xml · nonDerivative · entry 2 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,408 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 16, 2018 Filed Jan 18, 2018 21:49 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionCommon Stock | 3,400 | $16.62 | $56,508.00 |
DisclosureSEC source: 0001209191-18-004280 · doc4.xml · nonDerivative · entry 1 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,208 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 15, 2017 Filed Dec 19, 2017 22:44 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionStock Option (right to buy) · Derivative | 3,400 | $0.00 Strike: $44.19 | $0.00 |
DisclosureSEC source: 0001209191-17-066445 · doc4.xml · derivative · entry 12 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,200 Underlying: Common Stock · 3,400 shares Expires 2023-05-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_date: Subject to the reporting person's continuing service, twenty-five percent (25%) of the shares subject to the option shall vest and become exercisable on the one year anniversary of the vesting commencement date, and thereafter, one forty-eighth (1/48th) of the shares subject to the option shall vest each month on the same day as the vesting commencement date, such that the shares subject to the option shall become fully vested and exercisable on the fourth (4th) anniversary of the vesting commencement date. The vesting commencement date for this option is May 1, 2016. Read SEC document |
| December 15, 2017 Filed Dec 19, 2017 22:44 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionStock Option (right to buy) · Derivative | 6,200 | $0.00 Strike: $38.54 | $0.00 |
DisclosureSEC source: 0001209191-17-066445 · doc4.xml · derivative · entry 11 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,600 Underlying: Common Stock · 6,200 shares Expires 2022-05-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: Subject to the reporting person's continuing service, twenty-five percent (25%) of the shares subject to the option shall vest and become exercisable on the one year anniversary of the vesting commencement date, and thereafter, one forty-eighth (1/48th) of the total shares subject to the option shall vest each month on the same day as the vesting commencement date. The vesting commencement date for this option is May 1, 2015. Read SEC document |
| December 15, 2017 Filed Dec 19, 2017 22:44 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionStock Option (right to buy) · Derivative | 3,400 | $0.00 Strike: $16.62 | $0.00 |
DisclosureSEC source: 0001209191-17-066445 · doc4.xml · derivative · entry 10 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,556 Underlying: Common Stock · 3,400 shares Expires 2021-03-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: Subject to the reporting person's continuing service, 1/48th of the total shares subject to the option shall vest every month after March 1, 2014. Read SEC document |
| December 15, 2017 Filed Dec 19, 2017 22:44 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionStock Option (right to buy) · Derivative | 1,000 | $0.00 Strike: $8.37 | $0.00 |
DisclosureSEC source: 0001209191-17-066445 · doc4.xml · derivative · entry 9 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,037 Underlying: Common Stock · 1,000 shares Expires 2023-10-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: Subject to the reporting person's continuing service, one forty-eighth (1/48th) of the shares subject to the option shall vest each month on the same day as the vesting commencement date, such that the shares subject to the option shall become fully vested and exercisable on the fourth (4th) anniversary of the vesting commencement date. The vesting commencement date for this option is October 1, 2013. Read SEC document |
| December 15, 2017 Filed Dec 19, 2017 22:44 UTC | Inogen Inc INGN · Entity 2083 | SaleCommon Stock | 1,988 | $121.28 | $241,106.43 |
DisclosureSEC source: 0001209191-17-066445 · doc4.xml · nonDerivative · entry 8 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,808 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 3, 2017. F5 · price: Represents the weighted average share price of an aggregate total of 1,988 shares sold in the price range of $121.02 to $121.84 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.